Penumbra, Inc. to Present at Upcoming Investor Conferences


Werte in diesem Artikel
Aktien

279.60 EUR -1.00 EUR -0.36 %

ALAMEDA, Calif., May 20, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the following investor conferences on the dates and times listed below.

Penumbra, Inc. (PRNewsfoto/Penumbra, Inc.)

Event:

William Blair 45th Annual Growth Stock Conference

Date:

Tuesday, June 3, 2025

Time:

3:00pm ET/12:00pm PT

 

Event:

Jefferies Global Healthcare Conference

Date:

Wednesday, June 4, 2025

Time:

9:55am ET/6:55am PT

 

Event:

Truist Securities MedTech Conference

Date:

Tuesday, June 17, 2025

Time:

10:00am ET/7:00am PT

Webcasts of the presentations can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcasts will be available on the company's website for at least two weeks following each event.

About Penumbra 
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn and X.

Investor Relations

Penumbra, Inc.

investors@penumbrainc.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-upcoming-investor-conferences-302442997.html

SOURCE Penumbra, Inc.

Aktuelle Penumbra Aktie News

Werbung

Penumbra Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Penumbra nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
Datum Rating Analyst
15.12.17 Penumbra Market Perform BMO Capital Markets
24.10.16 Penumbra Outperform BMO Capital Markets
30.11.15 Penumbra Buy Canaccord Adams

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.